我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

阿托伐他汀对家兔颈动脉粥样硬化斑块内巨噬细胞浸润和平滑肌肌动蛋白表达的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第1期
页码:
46-50
栏目:
基础研究
出版日期:
2010-10-27

文章信息/Info

Title:
Effect of atorvastatin on expression of macrophage and smooth muscle actin in carotid atherosclerotic plaques in rabbits
作者:
于熙滢1; 曹海利2; 刘雅君1; 刘洋1; 李晓光1; 班翔3; 魏林1
1.哈尔滨市第一医院心内一科，黑龙江 哈尔滨 150010；哈尔滨医科大学：2.附属第二医院介入科，3.病理学教研室，黑龙江 哈尔滨 150086
Author(s):
YU Xi-ying1;  CAO Hai-li2;  LIU Ya-jun1;  LIU Yang1;  LI Xiao-guang1;  BAN Xiang3;  WEI Lin1
1.Department of Cardiology, Harbin First Hospital, Harbin 150010, Heilongjiang, China; 2.Department of Invasive Technology, Second Affiliated Hospital, 3.Department of Pathology, Harbin Medical University, Harbin 150086, Heilongjiang, China
关键词:
颈总动脉;  巨噬细胞; 平滑肌肌动蛋白; 阿托伐他汀; 家兔
Keywords:
common carotid artery;  macrophage;  smooth muscle actin;  atherosclerosis
分类号:
R543.5
DOI:
-
文献标识码:
A
摘要:
目的: 研究阿托伐他汀对家兔颈动脉粥样硬化(AS)斑块内巨噬细胞及平滑肌肌动蛋白(SMA)表达的影响，并探讨他汀类药物稳定AS斑块的机制。方法： 24只健康雄性新西兰大耳白兔随机分为对照组（n=8）和高胆固醇血症组（n=16）。16只高胆固血症组的家兔喂饲高胆固醇饲料2周后，进行颈总动脉内膜球囊拉伤术，术后再随机等分为AS模型组和阿托伐他汀组［给予阿托伐他汀5 mg/(kg·d)］，两组均继续喂饲高胆固醇饲料10周。喂养第12周时处死动物，取颈总动脉进行石蜡切片，用酶标法检测不同时间点血清脂质和脂蛋白；应用光学显微镜观察AS的进程；采用免疫组化染色法检测巨噬细胞浸润和SMA在斑块处的表达。结果： 阿托伐他汀组的血清总胆固醇(TC)及低密度脂蛋白-胆固醇(LDL-C)的浓度明显低于AS模型组(P<0.01)，颈总动脉内膜的厚度较AS模型组显著变薄［(0.49±0.072) vs.(0.66±0.08) mm,P<0.05］。免疫组化染色法检测结果示，阿托伐他汀组血管壁中巨噬细胞的数量显著较模型组减少(P<0.05)而SMA的表达较AS模型组显著增多(P<0.01)。结论： 阿托伐他汀可能通过抑制AS斑块内巨噬细胞的浸润并增强SMA的表达，而发挥稳定斑块的作用。
Abstract:
AIM: To observe inflammatory macrophages and smooth muscle actin in carotid atherosclerotic plaques in rabbits and the effects of atorvastatin on them and to explore whether statins could stabilize carotid plaques and its possible mechanism. METHODS: Twenty-four rabbits were randomly divided into three groups: control group (n=8) and hypercholesterolemia group (n=16). The hypercholesterolemia group was fed a hypercholesterol diet for 2 weeks and then catheter-induced arterial wall injury was made. Rabbits in hypercholesterolemia and aortic injury group were randomized into model group (n=8) and atorvastatin group 5 mg/(kg·day) for 10 weeks (n=8). Carotid arteries were isolated and paraffin-embedded slices were obtained. Blood lipids and lipoproteins were detected and the development of atherosclerotic plaques was evaluated by light microscopy. The levels of macrophages and smooth muscle actin in the common carotid artery were measured by immunohistochemical analysis. RESULTS: Serum concentrations of TC and LDL-C in atorvastatin group were lower than those in hypercholesterolemia model group (P<0.01). The intimal-medial thickness ［(0.49±0.072)mm vs.(0.66±0.079)mm, P<0.05］ in atorvastatin group was significantly less than that in hypercholesterolemia model group. Immunohistochemical analysis showed much less stain in macrophages in atorvastatin group compared with that in hypercholesterolemia model group. More smooth muscle actin was observed in atherosclerotic plaque than that in atorvastatin group. CONCLUSIONS: Atorvastatin may decrease the level of macrophages in atherosclerotic plaque and increase the development of smooth muscle actin, thus prohibiting the formation and development of atherosclerosis.

参考文献/References

[1]Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms[J]. Nat Rev Drug Discov, 2005, 4(12):977-987.

[2]Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization[J]. Stroke, 2006, 37(7):1923-1932.

[3]Gerdes N, Sukhova GK, Libby P, et al. Expression of interleukin(IL) -18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, end macrophages; implications for atherogenesis[J]. J Exp Med, 2002, 195(2):245-257.

[4]Michael T, James H, Zahi A, et al. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: A comparison with18F-FDG PET/CT and histology[J]. J Nucl Med, 2009, 50（6）:959-965.

[5]Yilmaz A, Lipfert B, Cicha I, et al. A cumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques[J]. Exp Mol Pathol, 2007, 82（5）:245-255.

[6]Constantinides P, Chakravarti RN. Rabbit arterial thrombosis production by systemic procedures[J]. Arch Pathol, 1961, 72:197-208.

[7]Sacco RL, Liao JK. Drug Insight: statins and stroke[J]. Nat Clin Pract Cardiovasc Med, 2005, 2（11）:576-584.

[8]Zhao SP, Zhang DQ. A torvastatin enhances cellular uptake of oxidized LDL in adipocytes from hypercholesterolemic rabbits[J]. Clin Chim Acta, 2004, 339（12）:189-194.

[9] Robert G, Dorota A, Wesley D, et al. Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits Using “Positive Contrast” magnetic resonance imaging[J]. J Am Coll Cardiol, 2008, 52（4）:483-491.

[10]Gómez-Hernández A, Sánchez-Galán E, Martín-Ventura JL, et al. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization[J]. J Cardiovasc Pharmacol, 2006, 47（7）:60-69.

[11]Souza-Costa DC, Sandrim VC, Lopes LF, et al. Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene[J]. Atherosclerosis, 2007, 49（11）:438-444.

备注/Memo

备注/Memo:
收稿日期：2010-02-04.通讯作者：魏林，主任医师 主要从事冠心病的介入治疗Email:yuxiying7505@163.com 作者简介：于熙滢，主治医师，硕士Email:xiyingyu@sina.com
更新日期/Last Update: 2010-10-27